The Immune System in Tissue Environments Regaining Homeostasis after Injury: Is "Inflammation" Always Inflammation?

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Kulkarni, Onkar P ^a   Lichtnekert, Julia ^b   Anders, Hans Joachim ^b   Mulay, Shrikant R ^b  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE;

FIBROSIS; HOMEOSTASIS; IMMUNE SYSTEM; IMMUNOREGULATION; INFECTION; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE; NONHUMAN; PROTEIN EXPRESSION; REVIEW; TISSUE INJURY; TISSUE REGENERATION; TISSUE REPAIR; ANIMAL; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; INFLAMMATION;

EID: 84983770579     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/2856213     Document Type: Review

References (136)

1. C. Nathan, "Points of control in inflammation," Nature, vol. 420, no. 6917, pp. 846-852, 2002
2. J. H. Hagemann, H. Haegele, S. Müller, and H.-J. Anders, "Danger control programs cause tissue injury and remodeling," International Journal of Molecular Sciences, vol. 14, no. 6, pp. 11319-11346, 2013
3. F. Adams, The Genuine Works of Hippocrates, The Sydenham Society, London, UK, 1849
4. J. F. Cohnheim, "Ueber entzündung und eiterung," Virch Arch Path Anat, vol. 40, pp. 1-79, 1867
5. B. Pinegin, N. Vorobjeva, and V. Pinegin, "Neutrophil extracellular traps and their role in the development of chronic inflammation and autoimmunity," Autoimmunity Reviews, vol. 14, no. 7, pp. 633-640, 2015
6. C. N. Serhan, "Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways," Annual Review of Immunology, vol. 25, pp. 101-137, 2007
7. A. Ariel and C. N. Serhan, "Resolvins and protectins in the termination program of acute inflammation," Trends in Immunology, vol. 28, no. 4, pp. 176-183, 2007
8. M. Weidenbusch andH.-J. Anders, "Tissue microenvironments define and get reinforced by macrophage phenotypes in homeostasis or during inflammation, repair and fibrosis," Journal of Innate Immunity, vol. 4, no. 5-6, pp. 463-477, 2012
9. R. Medzhitov, "Origin and physiological roles of inflammation," Nature, vol. 454, no. 7203, pp. 428-435, 2008
10. B. Suárez-Alvarez, H. Liapis, and H. J. Anders, "Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology," Laboratory Investigation, vol. 96, no. 4, pp. 378-390, 2016
11. D. L. Drayton, S. Liao, R. H. Mounzer, and N. H. Ruddle, "Lymphoid organ development: from ontogeny to neogenesis," Nature Immunology, vol. 7, no. 4, pp. 344-353, 2006
12. M. C. Basil and B. D. Levy, "Specialized pro-resolving mediators: endogenous regulators of infection and inflammation," Nature Reviews Immunology, vol. 16, no. 1, pp. 51-67, 2016
13. I. Tabas and C. K. Glass, "Anti-inflammatory therapy in chronic disease: challenges and opportunities," Science, vol. 339, no. 6116, pp. 166-172, 2013
14. J. Dalli and C. N. Serhan, "Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators," Blood, vol. 120, no. 15, pp. e60-e72, 2012
15. J. Varga and S. A. Jimenez, "Stimulation of normal human fibroblast collagen production and processing by transforming growth factor-β," Biochemical and Biophysical Research Communications, vol. 138, no. 2, pp. 974-980, 1986
16. S. E. Malawista, A. D. B. Chevance, J. Van Damme, and C. N. Serhan, "Tonic inhibition of chemotaxis in human plasma," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 46, pp. 17949-17954, 2008
17. B. D. Levy,C. B. Clish, B. Schmidt, K. Gronert, andC. N. Serhan, "Lipid mediator class switching during acute inflammation: signals in resolution," Nature Immunology, vol. 2, no. 7, pp. 612-619, 2001
18. C. Godson, S. Mitchell, K. Harvey, N. A. Petasis, N. Hogg, and H. R. Brady, "Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocytederived macrophages," Journal of Immunology, vol. 164, no. 4, pp. 1663-1667, 2000
19. C. N. Serhan, "Pro-resolving lipid mediators are leads for resolution physiology," Nature, vol. 510, no. 7503, pp. 92-101, 2014
20. C. Barnig, M. Cernadas, S. Dutile et al., "Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma," Science Translational Medicine, vol. 5, no. 174, Article ID 174ra26, 2013
21. J. Dalli, M. Zhu,N. A. Vlasenko et al., "The novel 13S,14S-epoxymaresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype," The FASEB Journal, vol. 27, no. 7, pp. 2573-2583, 2013
22. R. Flierman and M. R. Daha, "The clearance of apoptotic cells by complement," Immunobiology, vol. 212, no. 4-5, pp. 363-370, 2007
23. D. Ricklin,G. Hajishengallis, K. Yang, and J. D. Lambris, "Complement: a key system for immune surveillance and homeostasis," Nature Immunology, vol. 11, no. 9, pp. 785-797, 2010
24. D. Park, C. Z. Han, M. R. Elliott et al., "Continued clearance of apoptotic cells critically depends on the phagocyte Ucp2 protein," Nature, vol. 477, no. 7363, pp. 220-224, 2011
25. M. Lucas, L. M. Stuart, J. Savill, and A. Lacy-Hulbert, "Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion," The Journal of Immunology, vol. 171, no. 5, pp. 2610-2615, 2003
26. M. Lech, R. Gröbmayr, M. Weidenbusch, and H.-J. Anders, "Tissues use resident dendritic cells and macrophages to maintain homeostasis and to regain homeostasis upon tissue injury: the immunoregulatory role of changing tissue environments," Mediators of Inflammation, vol. 2012, Article ID 951390, 15 pages, 2012
27. M. Schmid, C. Gemperle, N. Rimann, and M. Hersberger, "Resolvin D1 polarizes primary human macrophages toward a proresolution phenotype through GPR32," The Journal of Immunology, vol. 196, no. 8, pp. 3429-3437, 2016
28. K. N. Couper, D. G. Blount, and E. M. Riley, "IL-10: the master regulator of immunity to infection," The Journal of Immunology, vol. 180, no. 9, pp. 5771-5777, 2008
29. J. Deng, Y. Kohda, H. Chiao et al., "Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury," Kidney International, vol. 60, no. 6, pp. 2118-2128, 2001
30. R. Sabat, G. Grütz, K. Warszawska et al., "Biology of interleukin-10," Cytokine and Growth Factor Reviews, vol. 21, no. 5, pp. 331-344, 2010
31. L. Deban, R. C. Russo, M. Sironi et al., "Regulation of leukocyte recruitment by the long pentraxin PTX3," Nature Immunology, vol. 11, no. 4, pp. 328-334, 2010
32. M. Lech, C. Römmele, O. P. Kulkarni et al., "Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus," PLoS ONE, vol. 6, no. 5, article e20118, 2011
33. M. Lech, C. Römmele, R. Gröbmayr et al., "Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury," Kidney International, vol. 83, no. 4, pp. 647-661, 2013
34. N. Maugeri, P. Rovere-Querini, M. Slavich et al., "Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction," Journal of Immunology, vol. 187, no. 2, pp. 970-979, 2011
35. K. Daigo, M. Nakakido, R. Ohashi et al., "Protective effect of the long pentraxin PTX3 against histone-mediated endothelial cell cytotoxicity in sepsis," Science Signaling, vol. 7, no. 343, article ra88, 2014
36. K. Daigo and T. Hamakubo, "Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps," Frontiers in Immunology, vol. 3, article 378, 2012
37. E. Bonavita, S. Gentile, M. Rubino et al., "PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer," Cell, vol. 160, no. 4, pp. 700-714, 2015
38. S. Sawa,M. Lochner, N. Satoh-Takayama et al., "RORt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota," Nature Immunology, vol. 12, no. 4, pp. 320-328, 2011
39. G. F. Sonnenberg, L. A. Monticelli, T. Alenghat et al., "Innate lymphoid cells promote anatomical containment of lymphoidresident commensal bacteria," Science, vol. 336, no. 6086, pp. 1321-1325, 2012
40. H. Yang, P. Lundbäck, L. Ottosson et al., "Redox modification of cysteine residues regulates the cytokine activity of highmobility group box-1 (HMGB1)," Molecular Medicine, vol. 18, no. 2, pp. 250-259, 2012
41. M. Magna and D. S. Pisetsky, "The role ofHMGB1 in the pathogenesis of inflammatory and autoimmune diseases," Molecular Medicine, vol. 20, no. 1, pp. 138-146, 2014
42. E. Gomez Perdiguero, K. Klapproth, C. Schulz et al., "Tissueresident macrophages originate fromyolk-sac-derived erythromyeloid progenitors," Nature, vol. 518, no. 7540, pp. 547-551, 2015
43. S. Yona, K.-W. Kim, Y. Wolf et al., "Fatemapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis," Immunity, vol. 38, no. 1, pp. 79-91, 2013
44. T. A. Wynn, A. Chawla, and J. W. Pollard, "Macrophage biology in development, homeostasis and disease," Nature, vol. 496, no. 7446, pp. 445-455, 2013
45. J. M. Ruckh, J.-W. Zhao, J. L. Shadrach et al., "Rejuvenation of regeneration in the aging central nervous system," Cell Stem Cell, vol. 10, no. 1, pp. 96-103, 2012
46. M. Nahrendorf, F. K. Swirski, E. Aikawa et al., "The healing myocardium sequentially mobilizes twomonocyte subsets with divergent and complementary functions," Journal of Experimental Medicine, vol. 204, no. 12, pp. 3037-3047, 2007
47. L. Arnold, A. Henry, F. Poron et al., "Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis," The Journal of Experimental Medicine, vol. 204, no. 5, pp. 1057-1069, 2007
48. M. Saclier, H. Yacoub-Youssef, A. L. Mackey et al., "Differentially activated macrophages orchestrate myogenic precursor cell fate during human skeletal muscle regeneration," STEM CELLS, vol. 31, no. 2, pp. 384-396, 2013
49. J. E. Heredia, L. Mukundan, F. M. Chen et al., "Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration," Cell, vol. 153, no. 2, pp. 376-388, 2013
50. R. M. Seaberg and D. van der Kooy, "Stem and progenitor cells: the premature desertion of rigorous definitions," Trends in Neurosciences, vol. 26, no. 3, pp. 125-131, 2003
51. H.-J. Anders, P. Romagnani, and A. Mantovani, "Pathomechanisms: homeostatic chemokines in health, tissue regeneration, and progressive diseases," Trends inMolecularMedicine, vol. 20, no. 3, pp. 154-165, 2014
52. N. Kyritsis, C. Kizil, S. Zocher et al., "Acute inflammation initiates the regenerative response in the adult zebrafish brain," Science, vol. 338, no. 6112, pp. 1353-1356, 2012
53. Y. Yin, M. T. Henzl, B. Lorber et al., "Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells," Nature Neuroscience, vol. 9, no. 6, pp. 843-852, 2006
54. T. Kurimoto, Y. Yin, G. Habboub et al., "Neutrophils express oncomodulin and promote optic nerve regeneration," The Journal of Neuroscience, vol. 33, no. 37, pp. 14816-14824, 2013
55. L. Boulter, O. Govaere, T. G. Bird et al., "Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease," Nature Medicine, vol. 18, no. 4, pp. 572-579, 2012
56. L. Lasagni, L. Ballerini, M. L. Angelotti et al., "Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders," STEM CELLS, vol. 28, no. 9, pp. 1673-1685, 2010
57. S.-L. Lin, B. Li, S. Rao et al., "Macrophage Wnt7b is critical for kidney repair and regeneration," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 9, pp. 4194-4199, 2010
58. A. Doni, T. Musso, D. Morone et al., "An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode,"The Journal of Experimental Medicine, vol. 212, no. 6, pp. 905-925, 2015
59. C. W. Strey, M. Markiewski, D. Mastellos et al., "The proinflammatory mediators C3a and C5a are essential for liver regeneration," The Journal of Experimental Medicine, vol. 198, no. 6, pp. 913-923, 2003
60. Q. Guo, J. Cheng, J. Zhang et al., "Delayed post-injury administration of C5a improves regeneration and functional recovery after spinal cord injury in mice," Clinical and Experimental Immunology, vol. 174, no. 2, pp. 318-325, 2013
61. T. Haynes, A. Luz-Madrigal, E. S. Reis et al., "Complement anaphylatoxinC3a is a potent inducer of embryonic chick retina regeneration," Nature Communications, vol. 4, article 2312, 2013
62. K. Brecht, A. Weigert, J. Hu et al., "Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2," FASEB Journal, vol. 25, no. 7, pp. 2408-2417, 2011
63. C.-W. Hsu, R. A. Poché, J. E. Saik et al., "Improved angiogenesis in response to localized delivery of macrophage-recruiting molecules," PLoS ONE, vol. 10, no. 7, Article IDe0131643, 2015
64. P. Zordan, E. Rigamonti, K. Freudenberg et al., "Macrophages commit postnatal endothelium-derived progenitors to angiogenesis and restrict endothelial to mesenchymal transition during muscle regeneration," Cell Death and Disease, vol. 5, article e1031, 2014
65. F. Sallustio, L. De Benedictis, G. Castellano et al., "TLR2 plays a role in the activation of human resident renal stem/progenitor cells," The FASEB Journal, vol. 24, no. 2, pp. 514-525, 2010
66. F. Sallustio, V. Costantino, S. N. Cox et al., "Human renal stem/ progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle-shuttled decorin," Kidney International, vol. 83, no. 3, pp. 392-403, 2013
67. H.-J. Anders and L. Schaefer, "Beyond tissue injury-damageassociated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis," Journal of the American Society of Nephrology, vol. 25, no. 7, pp. 1387-1400, 2014
68. O. P. Kulkarni, I. Hartter, S. R. Mulay et al., "Toll-like receptor 4-induced IL-22 accelerates kidney regeneration," Journal of the American Society of Nephrology, vol. 25,no. 5, pp. 978-989, 2014
69. M. Weidenbusch, S. Rodler, and H.-J. Anders, "Interleukin-22 in kidney injury and regeneration," American Journal of Physiology-Renal Physiology, vol. 308, no. 10, pp. F1041-F1046, 2015
70. M.-J. Xu, D. Feng, H. Wang, Y. Guan, X. Yan, and B. Gao, "IL-22 ameliorates renal ischemia-reperfusion injury by targeting proximal tubule epithelium," Journal of the American Society of Nephrology, vol. 25, no. 5, pp. 967-977, 2014
71. C. A. Lindemans, M. Calafiore, A. M. Mertelsmann et al., "Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration," Nature, vol. 528, no. 7583, pp. 560-564, 2015
72. J. A. Dudakov, A. M. Hanash, and M. R. M. van den Brink, "Interleukin-22: immunobiology and pathology," Annual Review of Immunology, vol. 33, pp. 747-785, 2015
73. H. Pan, F. Hong, S. Radaeva, and B. Gao, "Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3," Cellular &Molecular Immunology, vol. 1, no. 1, pp. 43-49, 2004
74. J. A. Dudakov, A. M. Hanash, R. R. Jenq et al., "Interleukin-22 drives endogenous thymic regeneration in mice," Science, vol. 336, no. 6077, pp. 91-95, 2012
75. T. Hill, O. Krougly, E. Nikoopour et al., "The involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genes," Cell Regeneration, vol. 2, article 2, 2013
76. T. Vangansewinkel, N. Geurts, K. Quanten et al., "Mast cells promote scar remodeling and functional recovery after spinal cord injury via mouse mast cell protease 6," The FASEB Journal, vol. 30, no. 5, pp. 2040-2057, 2016
77. M. Lesurtel, R. Graf, B. Aleil et al., "Platelet-derived serotonin mediates liver regeneration," Science, vol. 312, no. 5770, pp. 104-107, 2006
78. P. Starlinger, A. Assinger, S. Haegele et al., "Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humans," Hepatology, vol. 60, no. 1, pp. 257-266, 2014
79. L. A. Monticelli, G. F. Sonnenberg, M. C. Abt et al., "Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus," Nature Immunology, vol. 12, no. 11, pp. 1045-1054, 2011
80. D. Burzyn,W. Kuswanto,D. Kolodinet al., "Aspecial population of regulatory T cells potentiatesmuscle repair," Cell, vol. 155, no. 6, pp. 1282-1295, 2013
81. W. Kuswanto, D. Burzyn, M. Panduro et al., "Poor repair of skeletal muscle in aging mice reflects a defect in local, interleukin-33-dependent accumulation of regulatory T cells," Immunity, vol. 44, no. 2, pp. 355-367, 2016
82. A. Castiglioni, G. Corna, E. Rigamonti et al., "FOXP3+ T cells recruited to sites of sterile skeletalmuscle injury regulate the fate of satellite cells and guide effective tissue regeneration," PLoS ONE, vol. 10, no. 5, Article IDe0128094, 2015
83. H.-J. Anders, "Four danger response programs determine glomerular and tubulointerstitial kidney pathology: clotting, inflammation, epithelial and mesenchymal healing," Organogenesis, vol. 8, no. 2, pp. 29-40, 2012
84. B. M. Stramer, R. Mori, and P. Martin, "The inflammationfibrosis link? A Jekyll and Hyde role for blood cells during wound repair," Journal of Investigative Dermatology, vol. 127, no. 5, pp. 1009-1017, 2007
85. J. Meissner, A. Irfan, R. Twerenbold et al., "Use of neutrophil count in early diagnosis and risk stratification of AMI," American Journal of Medicine, vol. 124, no. 6, pp. 534-542, 2011
86. T. C. Barnes, M. E. Anderson, S. W. Edwards, and R. J. Moots, "Neutrophil-derived reactive oxygen species in SSc," Rheumatology, vol. 51, no. 7, pp. 1166-1169, 2012
87. Y. Ma, A. Yabluchanskiy, and M. L. Lindsey, "Neutrophil roles in left ventricular remodeling following myocardial infarction," Fibrogenesis and Tissue Repair, vol. 6, no. 1, article 11, 2013
88. A. Takemasa, Y. Ishii, and T. Fukuda, "A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice," European Respiratory Journal, vol. 40, no. 6, pp. 1475-1482, 2012
89. R. Shiraki, N. Inoue, S. Kawasaki et al., "Expression of Toll-like receptors on human platelets," Thrombosis Research, vol. 113, no. 6, pp. 379-385, 2004
90. G. Andonegui, S. M. Kerfoot, K. McNagny, K. V. J. Ebbert, K. D. Patel, and P. Kubes, "Platelets express functional Toll-like receptor-4," Blood, vol. 106, no. 7, pp. 2417-2423, 2005
91. H. Sinno and S. Prakash, "Complements and the wound healing cascade: an updated review," Plastic Surgery International, vol. 2013, Article ID 146764, 7 pages, 2013
92. C. J. Scotton, M. A. Krupiczojc,M. Königshoff et al., "Increased local expression of coagulation factor X contributes to the fibrotic response in human andmurine lung injury,"TheJournal of Clinical Investigation, vol. 119, no. 9, pp. 2550-2563, 2009
93. A. Ameri, S. Kurachi, K. Sueishi,M. Kuwahara, and K. Kurachi, "Myocardial fibrosis in mice with overexpression of human blood coagulation factor IX," Blood, vol. 101, no. 5,pp. 1871-1873, 2003
94. H. Xu, F. Noria,M. J. Sandoval-Cooper et al., "Severe deficiency of coagulation FactorVII results in spontaneous cardiac fibrosis in mice," Journal of Pathology, vol. 217, no. 3, pp. 362-371, 2009
95. H. I. Kenawy, I. Boral, and A. Bevington, "Complementcoagulation cross-talk: a potential mediator of the physiological activation of complement by low pH," Frontiers in Immunology, vol. 6, article 215, 2015
96. M. Huber-Lang, J. V. Sarma, F. S. Zetoune et al., "Generation of C5a in the absence of C3: a new complement activation pathway," Nature Medicine, vol. 12, no. 6, pp. 682-687, 2006
97. E. Addis-Lieser, J. Köhl, and M. G. Chiaramonte, "Opposing regulatory roles of complement factor 5 in the development of bleomycin-induced pulmonary fibrosis," The Journal of Immunology, vol. 175, no. 3, pp. 1894-1902, 2005
98. S. Hillebrandt, H. E. Wasmuth, R. Weiskirchen et al., "Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans," Nature Genetics, vol. 37, no. 8, pp. 835-843, 2005
99. P. Boor, A. Konieczny, L. Villa et al., "Complement C5 mediates experimental tubulointerstitial fibrosis," Journal of theAmerican Society of Nephrology, vol. 18, no. 5, pp. 1508-1515, 2007
100. M. Sendler, G. Beyer, U. M. Mahajan et al., "Complement component 5 mediates development of fibrosis, via activation of stellate cells, in 2 mouse models of chronic pancreatitis," Gastroenterology, vol. 149, no. 3, pp. 765-776. e10, 2015
101. L. Bao, Y. Wang, M. Haas, and R. J. Quigg, "Distinct roles for C3a and C5a in complement-induced tubulointerstitial injury," Kidney International, vol. 80, no. 5, pp. 524-534, 2011
102. S. S. Aceves and S. J. Ackerman, "Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis," Immunology and Allergy Clinics of North America, vol. 29, no. 1, pp. 197-211, 2009
103. S. P. Levick, J. L. McLarty, D. B. Murray, R. M. Freeman, W. E. Carver, and G. L. Brower, "Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart," Hypertension, vol. 53, no. 6, pp. 1041-1047, 2009
104. P. Kanellakis, M. Ditiatkovski, G. Kostolias, and A. Bobik, "A pro-fibrotic role for interleukin-4 in cardiac pressure overload," Cardiovascular Research, vol. 95, no. 1, pp. 77-85, 2012
105. A. Veerappan, N. J. O'Connor, J. Brazin et al., "Mast cells: a pivotal role in pulmonary fibrosis," DNA and Cell Biology, vol. 32, no. 4, pp. 206-218, 2013
106. S. P. Levick,G. C. Melndez,E. Plante, J. L. McLarty, G. L. Brower, and J. S. Janicki, "Cardiac mast cells: the centrepiece in adverse myocardial remodelling," Cardiovascular Research, vol. 89, no. 1, pp. 12-19, 2011
107. M. L. Novak and T. J. Koh, "Phenotypic transitions of macrophages orchestrate tissue repair," The American Journal of Pathology, vol. 183, no. 5, pp. 1352-1363, 2013
108. M. Lech and H.-J. Anders, "Macrophages and fibrosis: how resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair," Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1832, no. 7, pp. 989-997, 2013
109. P. J. Murray and T. A. Wynn, "Protective and pathogenic functions ofmacrophage subsets," Nature Reviews Immunology, vol. 11, no. 11, pp. 723-737, 2011
110. S. Khanna, S. Biswas, Y. Shang et al., "Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice," PLoS ONE, vol. 5, no. 3,Article ID e9539, 2010
111. M. J. van Amerongen, M. C. Harmsen, N. Van Rooijen, A. H. Petersen, and M. J. A. Van Luyn, "Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice," American Journal of Pathology, vol. 170, no. 3, pp. 818-829, 2007
112. Y. Matsumoto, I.-K. Park, and K. Kohyama, "Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy," The Journal of Immunology, vol. 183, no. 7, pp. 4773-4781, 2009
113. D. Westermann, K. Savvatis, D. Lindner et al., "Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy," Circulation, vol. 124, no. 19, pp. 2082-2093, 2011
114. L. A. Murray, Q. Chen, M. S. Kramer et al., "TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P," The International Journal of Biochemistry & Cell Biology, vol. 43, no. 1, pp. 154-162, 2011
115. A. Leask and D. J. Abraham, "TGF-β signaling and the fibrotic response," FASEB Journal, vol. 18, no. 7, pp. 816-827, 2004
116. S.-J. Chen,W. Yuan,Y. Mori, A. Levenson,M. Trojanowska, and J. Varga, "Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β: involvement of Smad 3," Journal of Investigative Dermatology, vol. 112, no. 1, pp. 49-57, 1999
117. M. Shah, D. M. Foreman, and M. W. J. Ferguson, "Control of scarring in adultwounds by neutralising antibody to transforming growth factor α," The Lancet, vol. 339, no. 8787, pp. 213-214, 1992
118. K. Sharma, Y. Jin, J. Guo, and F. N. Ziyadeh, "Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZinduced diabetic mice," Diabetes, vol. 45, no. 4, pp. 522-530, 1996
119. F. Kuwahara, H. Kai, K. Tokuda et al., "Transforming growth factor-β function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats," Circulation, vol. 106, no. 1, pp. 130-135, 2002
120. A. B. Kulkarni and S. Karlsson, "Transforming growth factor-β1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease," The American Journal of Pathology, vol. 143, no. 1, pp. 3-9, 1993
121. E. P. Bottinger, J. J. Letterio, and A. B. Roberts, "Biology of TGF-β in knockout and transgenic mouse models," Kidney International, vol. 51, no. 5, pp. 1355-1360, 1997
122. M. Ikeuchi, H. Tsutsui, T. Shiomi et al., "Inhibition of TGF-β signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction," Cardiovascular Research, vol. 64, no. 3, pp. 526-535, 2004
123. A. Sica and A. Mantovani, "Macrophage plasticity and polarization: in vivo veritas," Journal of Clinical Investigation, vol. 122, no. 3, pp. 787-795, 2012
124. D. E. Sullivan, M. Ferris, H. Nguyen, E. Abboud, and A. R. Brody, "TNF-β induces TGF-β1 expression in lung fibroblasts at the transcriptional level via AP-1 activation," Journal of Cellular and Molecular Medicine, vol. 13, no. 8, pp. 1866-1876, 2009
125. J. S. Duffield, S. J. Forbes, C. M. Constandinou et al., "Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair," Journal of Clinical Investigation, vol. 115, no. 1, pp. 56-65, 2005
126. K. Ozturk, O. Kurt, T. Dogan et al., "Pentraxin 3 is a predictor for fibrosis and arterial stiffness in patients with nonalcoholic fatty liver disease," Gastroenterology Research and Practice, vol. 2016, Article ID1417962, 7 pages, 2016
127. D. Pilling,N. Cox, V. Vakil, J. S. Verbeek, and R. H. Gomer, "The long pentraxin PTX3 promotes fibrocyte differentiation," PLoS ONE, vol. 10, no. 3, Article IDe119709, 2015
128. M. K. Connolly, A. S. Bedrosian, J. Mallen-StClair et al., "In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-β,"The Journal of Clinical Investigation, vol. 119, no. 11, pp. 3213-3225, 2009
129. C. Bantsimba-Malanda, J. Marchal-Sommé, D. Goven et al., "A role for dendritic cells in bleomycin-induced pulmonary fibrosis in mice?" American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 3, pp. 385-395, 2010
130. H. Y. Kim, H. J. Lee,Y.-J. Chang et al., "Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity," Nature Medicine, vol. 20, no. 1, pp. 54-61, 2014
131. M. S. Wilson, S. K. Madala, T. R. Ramalingamet al., "Bleomycin and IL-1-mediated pulmonary fibrosis is IL-17A dependent," The Journal of Experimental Medicine, vol. 207, no. 3, pp. 535-552, 2010
132. E. Hams, M. E. Armstrong, J. L. Barlow et al., "IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 1, pp. 367-372, 2014
133. S. R. Mulay, D. Thomasova, M. Ryu, and H.-J. Anders, "MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice," Kidney International, vol. 81, no. 12, pp. 1199-1211, 2012
134. S. R. Mulay, D. Thomasova, M. Ryu et al., "Podocyte loss involves MDM2-driven mitotic catastrophe," Journal of Pathology, vol. 230, no. 3, pp. 322-335, 2013
135. S. R. Mulay, S. R. Romoli, J. Desai et al., "Murine double minute-2 inhibition ameliorates established crescentic glomerulonephritis," The American Journal of Pathology, vol. 186, no. 6, pp. 1442-1453, 2016
136. G. Majno, The Healing Hand: Man and Wound in the Ancient World,Harward University Press, Cambridge,Mass, USA, 1975.